Cargando…
Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges
BACKGROUND: “Slam” has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with the use of psychostimulants, including synthetic cath...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387686/ https://www.ncbi.nlm.nih.gov/pubmed/32792999 http://dx.doi.org/10.3389/fpsyt.2020.00705 |
_version_ | 1783564176431513600 |
---|---|
author | Schreck, Benoit Guerlais, Marylène Laforgue, Edouard Bichon, Célia Grall-Bronnec, Marie Victorri-Vigneau, Caroline |
author_facet | Schreck, Benoit Guerlais, Marylène Laforgue, Edouard Bichon, Célia Grall-Bronnec, Marie Victorri-Vigneau, Caroline |
author_sort | Schreck, Benoit |
collection | PubMed |
description | BACKGROUND: “Slam” has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with the use of psychostimulants, including synthetic cathinones. METHODS: All spontaneous notifications (Nots) of slam practice reported between January 2012 and October 2019 at the Nantes addictovigilance center in France were collected and analyzed. The purpose of this work was to analyze cases of slam to characterize cathinone use disorder according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and to further our knowledge of slam practice based on data on drug use, risk taking and harmful consequences. RESULTS: We collected 39 slam Nots. The severity of cathinone use disorder was mild, moderate and severe for 18%, 12%, and 58% of the patients, respectively. “Much time spent using cathinone” was the diagnostic criterion most often cited (82%). CONCLUSIONS: To the best of our knowledge, our study is the first to evaluate the presence of a cathinone use disorder. Cathinone use disorder seems particularly important in this population of users, and negative consequences of slam practice appear quickly. |
format | Online Article Text |
id | pubmed-7387686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73876862020-08-12 Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges Schreck, Benoit Guerlais, Marylène Laforgue, Edouard Bichon, Célia Grall-Bronnec, Marie Victorri-Vigneau, Caroline Front Psychiatry Psychiatry BACKGROUND: “Slam” has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with the use of psychostimulants, including synthetic cathinones. METHODS: All spontaneous notifications (Nots) of slam practice reported between January 2012 and October 2019 at the Nantes addictovigilance center in France were collected and analyzed. The purpose of this work was to analyze cases of slam to characterize cathinone use disorder according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and to further our knowledge of slam practice based on data on drug use, risk taking and harmful consequences. RESULTS: We collected 39 slam Nots. The severity of cathinone use disorder was mild, moderate and severe for 18%, 12%, and 58% of the patients, respectively. “Much time spent using cathinone” was the diagnostic criterion most often cited (82%). CONCLUSIONS: To the best of our knowledge, our study is the first to evaluate the presence of a cathinone use disorder. Cathinone use disorder seems particularly important in this population of users, and negative consequences of slam practice appear quickly. Frontiers Media S.A. 2020-07-22 /pmc/articles/PMC7387686/ /pubmed/32792999 http://dx.doi.org/10.3389/fpsyt.2020.00705 Text en Copyright © 2020 Schreck, Guerlais, Laforgue, Bichon, Grall-Bronnec and Victorri-Vigneau http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Schreck, Benoit Guerlais, Marylène Laforgue, Edouard Bichon, Célia Grall-Bronnec, Marie Victorri-Vigneau, Caroline Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges |
title | Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges |
title_full | Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges |
title_fullStr | Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges |
title_full_unstemmed | Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges |
title_short | Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges |
title_sort | cathinone use disorder in the context of slam practice: new pharmacological and clinical challenges |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387686/ https://www.ncbi.nlm.nih.gov/pubmed/32792999 http://dx.doi.org/10.3389/fpsyt.2020.00705 |
work_keys_str_mv | AT schreckbenoit cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges AT guerlaismarylene cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges AT laforgueedouard cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges AT bichoncelia cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges AT grallbronnecmarie cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges AT victorrivigneaucaroline cathinoneusedisorderinthecontextofslampracticenewpharmacologicalandclinicalchallenges |